Eric Benevich Neurocrine Biosciences Inc (NBIX) insider trading activity

Eric Benevich is Chief Commercial Officer of NEUROCRINE BIOSCIENCES INC. Currently has a direct ownership of 41,919 shares of NBIX, which is worth approximately $6.31 Million. The most recent transaction as insider was on Nov 03, 2022, when has been sold 8,968 shares (Common Stock) at a price of $125.02 per share, resulting in proceeds of $1,121,179. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 41.9K

2.8% 3M change

8.18% 12M change

Total Value Held $6.31 Million

ERIC BENEVICH Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 03 2022	SELL Open market or private sale	$1,121,179 $125.02 p/Share	8,968 Reduced 36.44%	15,643 Common Stock
Nov 03 2022	BUY Exercise of conversion of derivative security	$374,683 $41.78 p/Share	8,968 Added 26.71%	24,611 Common Stock
Nov 02 2022	SELL Open market or private sale	$50,000 $125.0 p/Share	400 Reduced 2.49%	15,643 Common Stock
Nov 02 2022	BUY Exercise of conversion of derivative security	$16,712 $41.78 p/Share	400 Added 2.43%	16,043 Common Stock
Oct 17 2022	SELL Open market or private sale	$549,667 $110.82 p/Share	4,960 Reduced 24.07%	15,643 Common Stock
Feb 08 2022	SELL Open market or private sale	$78,077 $79.67 p/Share	980 Reduced 4.6%	20,338 Common Stock
Feb 07 2022	SELL Open market or private sale	$332,650 $80.76 p/Share	4,119 Reduced 17.47%	19,459 Common Stock
Aug 16 2021	SELL Open market or private sale	$504,381 $89.62 p/Share	5,628 Reduced 26.5%	15,608 Common Stock
Feb 08 2021	SELL Open market or private sale	$498,864 $116.83 p/Share	4,270 Reduced 16.83%	21,099 Common Stock
Feb 05 2021	SELL Open market or private sale	$92,250 $114.03 p/Share	809 Reduced 4.69%	16,434 Common Stock
Jan 26 2021	SELL Open market or private sale	$48,000 $120.0 p/Share	400 Reduced 2.48%	15,705 Common Stock
Jan 26 2021	BUY Exercise of conversion of derivative security	$12,534 $41.78 p/Share	300 Added 1.83%	16,105 Common Stock
Jan 25 2021	SELL Open market or private sale	$609,392 $120.03 p/Share	5,077 Reduced 24.31%	15,805 Common Stock
Jan 25 2021	BUY Exercise of conversion of derivative security	$145,269 $41.78 p/Share	3,477 Added 14.27%	20,882 Common Stock
Nov 12 2020	SELL Open market or private sale	$204,732 $90.71 p/Share	2,257 Reduced 11.48%	17,405 Common Stock
Nov 02 2020	SELL Open market or private sale	$1,988,035 $96.53 p/Share	20,595 Reduced 57.26%	15,374 Common Stock
Nov 02 2020	BUY Exercise of conversion of derivative security	$741,214 $35.99 p/Share	20,595 Added 36.41%	35,969 Common Stock

Also insider at

LIFE

aTYR PHARMA INC Healthcare

Eric Benevich

Chief Commercial Officer

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NBIX shares.

Notify only if

Value

Insider Trading

Get notified when an Neurocrine Biosciences Inc insider buys or sells NBIX shares.

Notify only if

Operation

Value

Type

News

Receive news related to NEUROCRINE BIOSCIENCES INC

Track Activities on NBIX

Account